SOURCE: Equity Markets Inc

October 26, 2011 09:00 ET

What's Ahead: Today's Economic Outlook -- Equity Research on Medtronic, Inc. and The Cooper Companies, Inc.

MACAU--(Marketwire - Oct 26, 2011) - Today, www.EquityMarketsInc.com announced its research report highlighting Medtronic, Inc. (NYSE: MDT) and The Cooper Companies, Inc. (NYSE: COO). Full content and research is available at www.EquityMarketsInc.com/research.php?id=MDT+COO.

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed Medtronic, Inc. for its current position within the healthcare industry. Medtronic, Inc. (Medtronic) is a medical technology company. The Company is engaged in research, design, manufacture and sale of products to alleviate pain, restore health and extend life. It manufactures and sells device-based medical therapies. The full research report on Medtronic, Inc. (NYSE: MDT) is available here: www.EquityMarketsInc.com/research.php?id=MDT.

Equity Markets has reviewed The Cooper Companies, Inc. for its development within the healthcare industry. The Cooper Companies, Inc. (Cooper) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the global vision correction market. The full research report on The Cooper Companies, Inc. (NYSE: COO) is available here: www.EquityMarketsInc.com/research.php?id=COO.

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information